Daiichi Sankyo Company, Limited (DSKYF)
USD 26.5
(0.0%)
USD 26.5
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 | 104.62 JPY | 83.67% |
| 2023 | 56.96 JPY | 63.02% |
| 2022 | 34.94 JPY | -10.8% |
| 2021 | 39.17 JPY | -41.01% |
| 2020 | 66.40 JPY | 38.13% |
| 2019 | 48.07 JPY | 57.92% |
| 2018 | 30.44 JPY | 14.69% |
| 2017 | 26.54 JPY | -33.3% |
| 2016 | 39.79 JPY | -73.91% |
| 2015 | 152.52 JPY | 428.48% |
| 2014 | 28.86 JPY | -4.82% |
| 2013 | 30.32 JPY | 516.26% |
| 2012 | 4.92 JPY | -85.19% |
| 2011 | 33.21 JPY | 67.56% |
| 2010 | 19.82 JPY | 119.54% |
| 2009 | -101.41 JPY | -324.76% |
| 2008 | 45.12 JPY | 25.61% |
| 2007 | 35.92 JPY | -9.82% |
| 2006 | 39.83 JPY | 6.9% |
| 2005 | 37.26 JPY | 13.39% |
| 2004 | 32.86 JPY | 29.98% |
| 2003 | 25.28 JPY | -11.58% |
| 2002 | 28.59 JPY | -8.04% |
| 2001 | 31.09 JPY | -0.06% |
| 2000 | 31.11 JPY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 29.74 JPY | 153.54% |
| 2024 FY | - JPY | 83.8% |
| 2024 Q3 | 34.71 JPY | 66.4% |
| 2024 Q4 | 19.38 JPY | -44.17% |
| 2024 Q2 | 20.86 JPY | -29.86% |
| 2023 Q4 | 11.73 JPY | -20.8% |
| 2023 FY | - JPY | 63.02% |
| 2023 Q3 | 14.81 JPY | -28.04% |
| 2023 Q2 | 20.58 JPY | 109.36% |
| 2023 Q1 | 9.83 JPY | 168.89% |
| 2022 Q2 | 14.22 JPY | -22.63% |
| 2022 Q1 | 18.38 JPY | 23165.82% |
| 2022 Q4 | -14.27 JPY | -185.86% |
| 2022 FY | - JPY | -10.8% |
| 2022 Q3 | 16.62 JPY | 16.88% |
| 2021 Q1 | 16.38 JPY | 711.19% |
| 2021 Q2 | 10.18 JPY | -37.85% |
| 2021 Q3 | 12.43 JPY | 22.1% |
| 2021 Q4 | 0.08 JPY | -99.36% |
| 2021 FY | - JPY | -41.01% |
| 2020 Q3 | 35.94 JPY | 231.55% |
| 2020 Q2 | 10.84 JPY | -51.39% |
| 2020 Q1 | 22.30 JPY | 196.54% |
| 2020 FY | - JPY | 38.13% |
| 2020 Q4 | -2.68 JPY | -107.46% |
| 2019 Q4 | 7.52 JPY | -57.99% |
| 2019 Q3 | 17.90 JPY | 73.45% |
| 2019 Q2 | 10.32 JPY | -16.3% |
| 2019 FY | - JPY | 57.92% |
| 2019 Q1 | 12.33 JPY | 296.03% |
| 2018 Q2 | 2.58 JPY | -82.39% |
| 2018 Q4 | -6.29 JPY | -132.57% |
| 2018 Q3 | 19.31 JPY | 648.45% |
| 2018 FY | - JPY | 14.69% |
| 2018 Q1 | 14.65 JPY | 184.0% |
| 2017 Q4 | -17.44 JPY | -188.71% |
| 2017 Q3 | 19.66 JPY | 116.52% |
| 2017 Q2 | 9.08 JPY | -39.18% |
| 2017 Q1 | 14.93 JPY | 207.64% |
| 2017 FY | - JPY | -33.3% |
| 2016 Q1 | 16.59 JPY | 255.77% |
| 2016 Q4 | -13.87 JPY | -171.02% |
| 2016 FY | - JPY | -73.91% |
| 2016 Q3 | 19.53 JPY | 12.82% |
| 2016 Q2 | 17.31 JPY | 4.34% |
| 2015 FY | - JPY | 428.48% |
| 2015 Q2 | 14.37 JPY | 51.9% |
| 2015 Q3 | 24.58 JPY | 71.05% |
| 2015 Q4 | -10.65 JPY | -143.33% |
| 2015 Q1 | 9.46 JPY | 243.12% |
| 2014 Q3 | 17.97 JPY | 105.61% |
| 2014 Q1 | 7.11 JPY | -0.7% |
| 2014 FY | - JPY | -4.82% |
| 2014 Q4 | -6.61 JPY | -136.78% |
| 2014 Q2 | 8.74 JPY | 22.93% |
| 2013 Q2 | 1.87 JPY | -80.64% |
| 2013 Q4 | 7.16 JPY | -44.28% |
| 2013 FY | - JPY | 516.26% |
| 2013 Q1 | 9.66 JPY | 0.0% |
| 2013 Q3 | 12.85 JPY | 587.17% |
| 2012 FY | - JPY | -85.19% |
| 2012 Q1 | 11.99 JPY | 0.0% |
| 2012 Q2 | - JPY | -100.0% |
| 2012 Q3 | - JPY | 0.0% |
| 2012 Q4 | - JPY | 0.0% |
| 2011 Q3 | 13.03 JPY | 44.14% |
| 2011 FY | - JPY | 67.56% |
| 2011 Q4 | - JPY | -100.0% |
| 2011 Q2 | 9.04 JPY | -42.27% |
| 2011 Q1 | 15.66 JPY | 0.0% |
| 2010 Q2 | 12.09 JPY | 490.0% |
| 2010 Q3 | 9.89 JPY | -18.2% |
| 2010 Q4 | - JPY | -100.0% |
| 2010 FY | - JPY | 119.54% |
| 2010 Q1 | -3.10 JPY | 0.0% |
| 2009 Q2 | 4.03 JPY | 0.0% |
| 2009 Q3 | -157.11 JPY | -3998.51% |
| 2009 Q4 | - JPY | 100.0% |
| 2009 FY | - JPY | -324.76% |
| 2008 FY | - JPY | 25.61% |
| 2007 FY | - JPY | -9.82% |
| 2006 FY | - JPY | 6.9% |
| 2005 FY | - JPY | 13.39% |
| 2004 FY | - JPY | 29.98% |
| 2003 FY | - JPY | -11.58% |
| 2002 FY | - JPY | -8.04% |
| 2001 FY | - JPY | -0.06% |
| 2000 FY | - JPY | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| AstraZeneca PLC | 3.84 USD | -2624.479% |
| Bristol-Myers Squibb Company PFD CONV 2 | 3.88 USD | -2596.392% |
| CSPC Pharmaceutical Group Limited | 0.07 USD | -149357.143% |
| Clarus Therapeutics Holdings, Inc. | -8.04 USD | 1401.244% |
| Novartis AG | 7.63 USD | -1271.166% |
| PT Kalbe Farma Tbk. | 0.00 USD | -2682464.103% |